about
Radiation treatment with volumetric modulated arc therapy of hepatocellular carcinoma patients. Early clinical outcome and toxicity profile from a retrospective analysis of 138 patients.Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients.Endoscopic features of radiation gastritis after irradiation of hepatocellular carcinoma.Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.The Mini Nutritional Assessment (MNA) predicts care need in older Taiwanese: results of a national cohort study.Predicting emerging care-need with simple functional indicators: Findings from a national cohort study in Taiwan.Mini-nutritional assessment predicts functional status and quality of life of patients with hepatocellular carcinoma in Taiwan.Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.Comparison of surgery or radiotherapy on complications and quality of life in patients with the stage IB and IIA uterine cervical cancer.Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy.Usefulness of the mini nutritional assessment in predicting the nutritional status of patients with liver cancer in Taiwan.Calf circumference is more effective than body mass index in predicting emerging care-need of older adults - Results of a national cohort studyRadiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments
P50
Q36517404-E2B5478E-BC3A-4D48-8F82-67394D1E541CQ37613015-CF6F9226-5A39-409D-B072-37835D1C8433Q38134588-57B143B2-692D-4CED-AFF0-3D26A2D143A3Q38677020-1E3811EC-B5F6-49C0-90BE-8493641162B8Q39236195-7D4A0181-77E1-4FB8-AA18-9C4A4BF46587Q40046206-14B34F86-122F-4634-9F48-38054EF517EFQ44961078-62C24884-C2EA-4B57-95AE-88BE5F732043Q46976010-26FD1070-FA44-462C-A3EB-107182A2766AQ49124342-12A11DE0-E860-49E1-BE87-CEDB888F907CQ53629819-077D5D36-B714-49E1-85CA-B3CF2A9CE73DQ53704336-74E01D34-7B93-4EC6-B6E0-82CD82899AE2Q85412392-D75F45F2-E530-45DD-8A26-6C322B790329Q86157833-9ED8BBCD-D257-44F5-B77A-31EA5C76D06D
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0001-6515-8077
@en
name
Wei-Chung Hsu
@ast
Wei-Chung Hsu
@en
Wei-Chung Hsu
@es
Wei-Chung Hsu
@sl
type
label
Wei-Chung Hsu
@ast
Wei-Chung Hsu
@en
Wei-Chung Hsu
@es
Wei-Chung Hsu
@sl
prefLabel
Wei-Chung Hsu
@ast
Wei-Chung Hsu
@en
Wei-Chung Hsu
@es
Wei-Chung Hsu
@sl
P106
P1153
55510913600
P31
P496
0000-0001-6515-8077